| Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma H Wang, L Liang, Q Dong, L Huan, J He, B Li, C Yang, H Jin, L Wei, C Yu, ... Theranostics 8 (10), 2814, 2018 | 175 | 2018 |
| Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response L Huan, T Guo, Y Wu, L Xu, S Huang, Y Xu, L Liang, X He Molecular cancer 19, 1-17, 2020 | 121 | 2020 |
| miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma J Lian, Y Jing, Q Dong, L Huan, D Chen, C Bao, Q Wang, F Zhao, J Li, ... Oncotarget 7 (3), 2672, 2016 | 96 | 2016 |
| NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α C Bao, Y Li, L Huan, Y Zhang, F Zhao, Q Wang, L Liang, J Ding, L Liu, ... Science signaling 8 (387), ra75-ra75, 2015 | 82 | 2015 |
| LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR‐10a‐5p/NCOR2 axis in hepatocellular carcinoma cells Y Wu, Y Zhou, L Huan, L Xu, M Shen, S Huang, L Liang Cancer science 110 (3), 973-984, 2019 | 67 | 2019 |
| LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α L Xu*, L Huan*, T Guo, Y Wu, Y Liu, Q Wang, S Huang, Y Xu, L Liang, ... Oncogene 39 (46), 7005-7018, 2020 | 66 | 2020 |
| MicroRNA‐127‐5p targets the biliverdin reductase B/nuclear factor‐κB pathway to suppress cell growth in hepatocellular carcinoma cells L Huan, C Bao, D Chen, Y Li, J Lian, J Ding, S Huang, L Liang, X He Cancer Science 107 (3), 258-266, 2016 | 65 | 2016 |
| LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma Y Zhou*, L Huan*, Y Wu, C Bao, B Chen, L Wang, S Huang, L Liang, X He Cancer letters 469, 399-409, 2020 | 59 | 2020 |
| An LTR retrotransposon-derived long noncoding RNA lncMER52A promotes hepatocellular carcinoma progression by binding p120-catenin Y Wu, Y Zhao, L Huan, J Zhao, Y Zhou, L Xu, Z Hu, Y Liu, Z Chen, L Wang, ... Cancer research 80 (5), 976-987, 2020 | 47 | 2020 |
| GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma Y Zhang, J Yao, L Huan, J Lian, C Bao, Y Li, C Ge, J Li, M Yao, L Liang, ... Cancer letters 356 (2), 978-984, 2015 | 40 | 2015 |
| Role of microRNAs in inflammation-associated liver cancer L Huan, LH Liang, XH He Cancer biology & medicine 13 (4), 407, 2016 | 29 | 2016 |
| Inflammation-induced LINC00665 increases the malignancy through activating PKR/NF-κB pathway in hepatocellular carcinoma J Ding, J Zhao, L Huan, Y Liu, Y Qiao, Z Wang, Z Chen, S Huang, Y Zhao, ... Hepatology 72 (5), 1666-1681, 2020 | 19 | 2020 |
| LncRNA RP11-295G20. 2 regulates hepatocellular carcinoma cell growth and autophagy by targeting PTEN to lysosomal degradation L Liang*, L Huan*, J Wang*, Y Wu, S Huang, X He Cell Discovery 7 (1), 1-14, 2021 | 13 | 2021 |
| Inhibition of inflammatory mediators contributes to the anti-inflammatory activity of KYKZL-1 via MAPK and NF-κB pathway GL Xu, YF Du, J Cheng, L Huan, SC Chen, SH Wei, ZN Gong, J Cai, T Qiu, ... Toxicology and applied pharmacology 272 (1), 221-229, 2013 | 10 | 2013 |
| Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature M Shen, S Li, Y Zhao, Y Liu, Z Liu, L Huan, Y Qiao, L Wang, L Han, ... Cell Death & Disease 13 (8), 732, 2022 | 6 | 2022 |
| Growth inhibitory effect of KYKZL-1 on Hep G2 cells via inhibition of AA metabolites and caspase-3 pathway and cell cycle arrest J Cheng, YF Du, ZY Xiao, LL Pan, W Li, L Huan, ZN Gong, SH Wei, ... Toxicology and applied pharmacology 274 (1), 96-106, 2014 | 6 | 2014 |
| Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL‐6‐STAT3 signalling L Chi, L Huan, C Zhang, H Wang, J Lu Journal of Cellular and Molecular Medicine 27 (15), 2150-2164, 2023 | 1 | 2023 |
